Freilinger A, Rosner M, Hanneder M, Hengstschläger M
Medical Genetics, Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.
Oncogene. 2008 Mar 27;27(14):2072-83. doi: 10.1038/sj.onc.1210844. Epub 2007 Oct 8.
Mutational activation of Ras promotes oncogenesis by controlling cell cycle regulation and cell survival. Ras-mediated activation of both, the PI3K/AKT pathway and the MEK/ERK pathway, can trigger downregulation of the function of tuberin to block the activities of mTOR and p70S6K. Here we demonstrate that Ras-induced cell survival is accompanied by upregulation of p70S6K activity. Ras harbors the potential to negatively affect tuberin-induced apoptosis and p70S6K inactivation. These effects of Ras were found to depend on its potential to regulate the MEK/ERK pathway. Experiments using tuberin-negative fibroblasts revealed that the potential of Ras to counteract apoptosis depends on functional tuberin. Taken together, we provide evidence that the function of Ras to trigger inactivation of tuberin plays a major role in the regulation of cell survival upon mutational activation of the oncogene Ras. This is the first description of a functional interaction between the tumor suppressor tuberin and the oncogene Ras in regulating apoptosis.
Ras的突变激活通过控制细胞周期调控和细胞存活来促进肿瘤发生。Ras介导的PI3K/AKT途径和MEK/ERK途径的激活,均可触发结节性硬化蛋白功能的下调,从而阻断mTOR和p70S6K的活性。在此,我们证明Ras诱导的细胞存活伴随着p70S6K活性的上调。Ras具有负面影响结节性硬化蛋白诱导的凋亡和p70S6K失活的潜力。发现Ras的这些效应取决于其调节MEK/ERK途径的潜力。使用结节性硬化蛋白阴性成纤维细胞进行的实验表明,Ras对抗凋亡的潜力取决于功能性结节性硬化蛋白。综上所述,我们提供的证据表明,Ras触发结节性硬化蛋白失活的功能在癌基因Ras突变激活后对细胞存活的调节中起主要作用。这是肿瘤抑制因子结节性硬化蛋白与癌基因Ras在调节凋亡方面功能相互作用的首次描述。